TMG's EBITDA grows to $103.3m in FY23

Its Singapore segment revenue was driven by higher bill sizes.

SGX-listed Thomson Medical Group (TMG) posted a EBITDA of $355.8m for FY 2023, higher than $109.7m in FY 2022 due to lower income project-related services.

It was also cushioned by the reduced government grant, according to its financial report.

The hospital group's net profit after tax was $41.1m in FY 2023 from $58.6m in FY 2022.

TMG's revenue in 2023 went up 6.6% from 2022 as patient count rises and healthcare spending increases.

The hospital segment grew 14.6% whilst in Singapore higher average bill sizes also rose.

"We remain focused on our plans to expand and enhance our medical centres and clinics in Singapore, including a multi-year asset enhancement initiative of our flagship hospital in Singapore," read the statement.

Follow the link for more news on

Thomson Medical

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia